Search

everythinglearnresearchcommunity

for

Search:↓

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Finasteride may improve prostate cancer treatment outcomes.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Provenge extends prostate cancer survival by about 4 months.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

DA-9401 helps protect rat testis from finasteride damage.